AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2012
Sep 5, 2012
34117_dirs_2012-09-05_55964ede-0066-4b35-8898-d6c54327b4a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-08-29
Reporting Person: JOHNSON BRUCE F (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| CopyTele, Inc. common stock | 4079188 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy) | $0.12 | 2017-08-30 | Common Stock (60000) | Direct | |
| Common Stock Purchase Warrant | $0.1786 | 2016-02-07 | Common Stock (700000) | Direct |
Footnotes
F1: Pursuant to CopyTele, Inc. 2010 Share Incentive Plan.
F2: Pursuant to a private placement by CopyTele, Inc. in February 2011.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6